Chemoinformaics analysis of Humulene-6,7-oxide
| Molecular Weight | 218.34 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 13 |
| Exact Molecular Weight | 218.167 | nRing | 2 |
| Solubility: LogS | -5.401 | nHRing | 1 |
| Solubility: LogP | 4.09 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 40.5214 |
| nHD | 0 | BPOL | 23.8066 |
| QED | 0.442 |
| Synth | 4.798 |
| Natural Product Likeliness | 3.433 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.481 |
| CACO-2 | -4.51 |
| MDCK | 0.0000155 |
| BBB | 0.164 |
| PPB | 0.942718 |
| VDSS | 1.189 |
| FU | 0.020587 |
| CYP1A2-inh | 0.109 |
| CYP1A2-sub | 0.6 |
| CYP2c19-inh | 0.699 |
| CYP2c19-sub | 0.815 |
| CYP2c9-inh | 0.294 |
| CYP2c9-sub | 0.882 |
| CYP2d6-inh | 0.395 |
| CYP2d6-sub | 0.883 |
| CYP3a4-inh | 0.157 |
| CYP3a4-sub | 0.299 |
| CL | 2.938 |
| T12 | 0.194 |
| hERG | 0.002 |
| Ames | 0.018 |
| ROA | 0.111 |
| SkinSen | 0.239 |
| Carcinogencity | 0.031 |
| EI | 0.514 |
| Respiratory | 0.086 |
| NR-Aromatase | 0.016 |
| Antiviral | Yes |
| Prediction | 0.893905 |